Resultados de la búsqueda 101-110 of 8028 for FSA eligible expenses 2026

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  8. Ensayos clínicos - Medicina cardiovascular

    A Study to Assess the Current FDA-approved ... The purpose of this study is to assess the feasibility of using the current FDA-approved ... © 1998-2026 Fundación ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Eligibility Criteria, keep current Eligibility ... Also eligible are (11) up to 6 donors with triple ... © 1998-2026 Fundación Mayo para la Educación y la ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...